Insmed (INSM) has a profit margin of -39.85%, below the Healthcare sector average of 17.63%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
The latest profit margin for INSM is -39.85% as of September 2026. That compares with -264.83% in the prior-year period — up 85.0% year over year. That is below the Healthcare sector average of 17.63%. Investors often review this figure alongside Insmed's historical trend and sector peers before judging valuation or financial health.
Over the past year, INSM's profit margin moved from -264.83% to -39.85% — a 85.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Insmed's valuation or profitability profile.
Against Healthcare companies, INSM currently prints -39.85% for profit margin, while the sector average sits near 17.63%. That is roughly 326.1% below the sector mean. Large gaps often invite a closer look at Insmed's growth, margins, and balance sheet.
Profit Margin shows how effectively Insmed converts resources into returns. At -39.85%, INSM may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -264.83% in the prior-year period — up 85.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting INSM's profit margin (-39.85%), review year-over-year change from -264.83%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.